MannKind Corp. (MNKD)
5.78
+0.27
(+4.90%)
USD |
NASDAQ |
Feb 06, 16:00
5.785
0.00 (0.00%)
After-Hours: 20:00
MannKind SG&A Expense (TTM) : 195.42M for Sept. 30, 2025
SG&A Expense (TTM) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
SG&A Expense (TTM) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
SG&A Expense (TTM) Benchmarks
| Amicus Therapeutics, Inc. | 353.07M |
| Keros Therapeutics, Inc. | 45.77M |
| BioMarin Pharmaceutical, Inc. | 973.41M |
| Ionis Pharmaceuticals, Inc. | 351.68M |
| Vertex Pharmaceuticals, Inc. | 1.644B |